Fasting fewer than 8 hours or more than 12 hours before a routine blood test did not significantly impact the results, new ...

Merck has decided to discontinue production of a combination antibiotic used in hospitals to target life-threatening ...

Even though studies have linked GLP-1s to development of nonarteritic anterior ischemic neuropathy, the risk is not great enough to warrant stopping the medication, according to a speaker at Academy ...

Treating dry eye disease with both Xiidra and Miebo led to significant improvements in signs and symptoms, with most patients ...

The FDA announced the approval of the first size-adjustable pulmonary valve replacement designed for children with congenital ...

Researchers developed and validated a new classification system that may standardize reporting of all relevant grades of ...

The FDA has granted 510(k) clearance to allow over-the-counter sale of a needle-free continuous glucose monitor, according to ...

In the 20 years since the FDA’s approval of rituximab for rheumatoid arthritis, trials and real-world use of B-cell depleting therapies have resulted in surprising successes and unexpected setbacks in ...

Ultraprocessed animal- and plant-based foods were associated with greater risks for developing chronic kidney disease among ...

Unlike clinicians in Europe, clinicians in North America did not have a guideline on managing bronchiectasis in adults, and ...

SpyGlass Pharma announced the acquisition of Advanced Vision Science in an effort to boost its IOL manufacturing capacity, ...

An investigational amylin receptor agonist combined with tirzepatide induced weight loss of up to 23.3% for adults with type ...